Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06195124
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2023-10-14
Brief Title:
A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinsons Disease
Sponsor:
Second Affiliated Hospital of Soochow University
Organization:
Second Affiliated Hospital of Soochow University
Study Overview
Official Title:
A Study on the Safety and Tolerability of RGL-193 Injection in Patients With Advanced Parkinsons Disease - An Open-label and Dose-escalation Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A safety study in patients with Parkinsons disease
Detailed Description:
This is an open-label dose-escalation safety and tolerability study in patients with advanced Parkinsons disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None